Shenzhen Weiguang Biological Products Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Q58
  • SHE: 002880
CNY
21.78
0.14 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
227.19
221.87
475.76
270.39
293.09
225.00
349.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
227.19
221.87
475.76
270.39
293.09
225.00
349.09
Raw Material Cost
171.03
144.64
321.02
169.33
165.61
136.96
206.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.83
4.29
6.63
5.08
5.32
4.65
7.27
Selling and Distribution Expenses
23.60
26.68
48.58
33.82
40.32
22.92
38.90
Other Expenses
0.25
0.36
-0.05
0.47
0.18
0.40
0.08
Total Expenditure (Excl Depreciation)
201.95
179.25
375.76
212.95
213.03
168.50
253.87
Operating Profit (PBDIT) excl Other Income
25.2
42.599999999999994
100
57.400000000000006
80.1
56.5
95.19999999999999
Other Income
4.02
3.23
7.41
3.52
3.17
3.21
9.00
Operating Profit (PBDIT)
63.82
82.39
147.08
104.38
116.80
93.96
133.37
Interest
4.83
4.29
6.63
5.08
5.32
4.65
7.27
Exceptional Items
0.00
0.00
1.87
0.00
0.00
0.00
-14.05
Gross Profit (PBDT)
56.15
77.23
154.74
101.06
127.48
88.04
142.17
Depreciation
38.92
38.92
43.41
43.41
36.29
36.29
31.97
Profit Before Tax
20.08
39.18
98.90
55.89
75.20
53.03
80.08
Tax
6.22
8.41
10.93
5.65
11.35
9.31
8.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.40
30.98
88.46
50.21
63.88
43.77
70.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.40
30.98
88.46
50.21
63.88
43.77
70.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.46
-0.21
-0.49
0.03
-0.03
-0.04
0.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.86
30.77
87.97
50.24
63.85
43.72
71.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,411.41
2,443.37
2,412.39
2,323.93
2,273.71
2,255.19
2,211.43
Earnings per share (EPS)
0.06
0.14
0.39
0.22
0.28
0.19
0.31
Diluted Earnings per share
0.06
0.14
0.39
0.22
0.28
0.19
0.31
Operating Profit Margin (Excl OI)
9.19%
18.14%
20.23%
21.24%
26.39%
24.21%
26.47%
Gross Profit Margin
25.97%
35.2%
29.91%
36.73%
38.04%
39.7%
32.1%
PAT Margin
5.9%
13.96%
18.59%
18.57%
21.79%
19.45%
20.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is -22.48% vs -1.18% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is -78.25% vs 1.59% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is -47.36% vs 5.28% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -9.43% vs -1.85% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Shenzhen Weiguang Biological Products Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
227.19
0
227.19
Other Operating Income
0.00
0.00
0.00
Total Operating income
227.19
0
227.19
Raw Material Cost
171.03
0
171.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.83
0
4.83
Selling and Distribution Expenses
23.60
0
23.60
Other Expenses
0.25
0.00
0.25
Total Expenditure (Excl Depreciation)
201.95
0
201.95
Operating Profit (PBDIT) excl Other Income
25.23
0.00
25.23
Other Income
4.02
0
4.02
Operating Profit (PBDIT)
63.82
0
63.82
Interest
4.83
0
4.83
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
56.15
0
56.15
Depreciation
38.92
0
38.92
Profit Before Tax
20.08
0
20.08
Tax
6.22
0
6.22
Provisions and contingencies
0
0
0.00
Profit After Tax
13.40
0
13.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13.40
0
13.40
Share in Profit of Associates
0
0
0.00
Minority Interest
0.46
0
0.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.86
0
13.86
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,411.41
0
2,411.41
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
9.19%
0%
0.00
9.19%
Gross Profit Margin
25.97%
0%
0.00
25.97%
PAT Margin
5.90%
0%
0.00
5.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 22.72 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.39% vs -53.36% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -22.48% vs -1.18% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.39 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -54.87% vs -65.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -78.25% vs 1.59% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.98 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -24.49% vs -43.31% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -47.36% vs 5.28% in Jun 2025

Quarterly - Interest
Interest 0.48 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 11.63% vs -34.85% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -9.43% vs -1.85% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.19%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025